Volume 1•Issue 2

Despite universal adoption of patient centricity rhetoric in life sciences, patient insights remain structurally fragmented across organizational functions and rarely influence enterprise-level decisions. This paper identifies the absence of a unifying ...

Attending a phlebotomy appointment can cause high levels of anxiety, especially in patients with learning disabilities (LD). This project explores the validation of blood tests using capillary blood versus routine venepuncture samples and looks at ...

Background: The Yellow Card Scheme was introduced in the UK in 1964 with an aim to address adverse drug reactions patient safety concerns. Medical devices are now included within the scope of reportable events. Aim: We report here what we believe is the ...

Background & aim: Lipoprotein(a) (Lp(a)) is an established predictor of cardiovascular risk. Recent evidence suggests that Lp(a) testing with subsequent intervention could be economically advantageous, and several organizations now recommend population ...